Cargando…

Recalling ancestral SARS-CoV-2 variants: is it an original sin with benefits?

Detalles Bibliográficos
Autores principales:	Hoehl, Sebastian, Ciesek, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2023
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886284/ https://www.ncbi.nlm.nih.gov/pubmed/36731478 http://dx.doi.org/10.1016/S1473-3099(23)00007-5

Ejemplares similares

SARS-CoV-2 immunity and HIV infection: total recall?
por: Dauby, Nicolas, et al.
Publicado: (2021)

Die Virologie von SARS-CoV-2
por: Hoehl, S., et al.
Publicado: (2020)

Die Virologie von SARS-CoV-2
por: Hoehl, S., et al.
Publicado: (2020)

Die Virologie von SARS-CoV-2
por: Hoehl, S., et al.
Publicado: (2020)

A new group at increased risk of a SARS-CoV-2 infection emerges: The recently vaccinated
por: Hoehl, Sebastian, et al.
Publicado: (2021)

Addendum: competing interests and the origins of SARS-CoV-2
por: Editors of The Lancet
Publicado: (2021)

Decoding the next SARS-CoV-2 variant
por: Nel, Jeremy, et al.
Publicado: (2022)

Balancing risk and benefit of SARS-CoV-2 vaccines in children
por: Levin, Michael, et al.
Publicado: (2022)

Assessment of SARS-CoV-2 Transmission on an International Flight and Among a Tourist Group
por: Hoehl, Sebastian, et al.
Publicado: (2020)

Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings
por: Widera, Marek, et al.
Publicado: (2021)

SARS-CoV-2 variants and ending the COVID-19 pandemic
por: Fontanet, Arnaud, et al.
Publicado: (2021)

Will SARS-CoV-2 variants of concern affect the promise of vaccines?
por: Gupta, Ravindra K.
Publicado: (2021)

The benefit of vaccination after previous SARS-CoV-2 infection in the omicron era
por: Boaventura, Viviane S, et al.
Publicado: (2023)

The recency and geographical origins of the bat viruses ancestral to SARS-CoV and SARS-CoV-2
por: Pekar, Jonathan E., et al.
Publicado: (2023)

SARS-CoV-2 variants and considerations of inferring causality on disease severity
por: Cevik, Muge, et al.
Publicado: (2021)

Managing waning vaccine protection against SARS-CoV-2 variants
por: Leung, Kathy, et al.
Publicado: (2022)

Are smokers protected against SARS-CoV-2 infection (COVID-19)? The origins of the myth
por: van Westen-Lagerweij, Naomi A., et al.
Publicado: (2021)

New year, new SARS-CoV-2 variant: Resolutions on genomic surveillance protocols to face Omicron
por: Oróstica, Karen Y., et al.
Publicado: (2022)

SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines
por: Thiruvengadam, Ramachandran, et al.
Publicado: (2022)

Travel measures in the SARS-CoV-2 variant era need clear objectives
por: Kucharski, Adam J, et al.
Publicado: (2022)

Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity
por: Markov, Peter V., et al.
Publicado: (2022)

Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficiencies
por: Nadesalingam, Angalee, et al.
Publicado: (2023)

Comparative analysis of point-of-care, high-throughput and laboratory-developed SARS-CoV-2 nucleic acid amplification tests (NATs)
por: Kohmer, Niko, et al.
Publicado: (2021)

What is the vaccine effect on reducing transmission in the context of the SARS-CoV-2 delta variant?
por: Wilder-Smith, Annelies
Publicado: (2022)

Importance of epidemiological factors in the evaluation of transmissibility and clinical severity of SARS-CoV-2 variants
por: Lechien, Jérôme R, et al.
Publicado: (2022)

Understanding how fast SARS-CoV-2 variants transmit from household studies
por: Yang, Yang, et al.
Publicado: (2022)

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
por: Karim, Salim S Abdool, et al.
Publicado: (2021)

Neutralizing antibodies and their cocktails against SARS-CoV-2 Omicron and other circulating variants
por: Yang, Yang, et al.
Publicado: (2022)

SARS-CoV-2 variants offer a second chance to fix vaccine inequities
por: Hotez, Peter J.
Publicado: (2022)

Is SARS-CoV-2 originated from laboratory? A rebuttal to the claim of formation via laboratory recombination
por: Hao, Pei, et al.
Publicado: (2020)

SARS-CoV-2 vaccination in the context of original antigenic sin
por: Petráš, Marek, et al.
Publicado: (2021)

Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread?
por: Toptan, Tuna, et al.
Publicado: (2021)

Possible effect of the “original antigenic sin” in vaccination against new variants of SARS-CoV-2()
por: Reina, J.
Publicado: (2022)

Global emergence of SARS-CoV-2 variants: new foresight needed for improved vaccine efficacy
por: Yadav, Pragya D, et al.
Publicado: (2022)

SARS-CoV-2 Lambda and Gamma variants competition in Peru, a country with high seroprevalence
por: Vargas-Herrera, Natalia, et al.
Publicado: (2021)

Asymptomatic SARS-CoV-2 infection
por: Ooi, Eng Eong, et al.
Publicado: (2020)

The complexities of SARS-CoV-2 serology
por: Houlihan, Catherine F, et al.
Publicado: (2020)

Neonatal SARS-CoV-2 infection
por: de Carvalho, Werther Brunow, et al.
Publicado: (2020)

Towards SARS-CoV-2 serotypes?
por: Simon-Loriere, Etienne, et al.
Publicado: (2022)

Novel multiple swab method enables high efficiency in SARS‐CoV‐2 screenings without loss of sensitivity for screening of a complete population
por: Schmidt, Michael, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lk2vjt0c1ttcvc2qf4041fd0b4